Bio Essence (BIOE) Debt to Equity (2020 - 2024)
Bio Essence has reported Debt to Equity over the past 5 years, most recently at -$0.9 for Q1 2024.
- Quarterly results put Debt to Equity at -$0.9 for Q1 2024, down 8783.16% from a year ago — trailing twelve months through Mar 2024 was -$0.9 (down 8783.16% YoY), and the annual figure for FY2023 was -$0.37, down 3118.2%.
- Debt to Equity for Q1 2024 was -$0.9 at Bio Essence, down from -$0.37 in the prior quarter.
- Over the last five years, Debt to Equity for BIOE hit a ceiling of -$0.01 in Q1 2023 and a floor of -$0.98 in Q3 2021.
- Median Debt to Equity over the past 5 years was -$0.02 (2021), compared with a mean of -$0.34.
- Biggest five-year swings in Debt to Equity: skyrocketed 98.64% in 2022 and later crashed 8783.16% in 2024.
- Bio Essence's Debt to Equity stood at -$0.74 in 2020, then skyrocketed by 97.24% to -$0.02 in 2021, then skyrocketed by 43.43% to -$0.01 in 2022, then tumbled by 3118.2% to -$0.37 in 2023, then crashed by 140.89% to -$0.9 in 2024.
- The last three reported values for Debt to Equity were -$0.9 (Q1 2024), -$0.37 (Q4 2023), and -$0.02 (Q3 2023) per Business Quant data.